USD 0.16
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 4.55 Million GBP | -8.94% |
2022 | 5 Million GBP | 113.9% |
2021 | 2.33 Million GBP | 71.66% |
2020 | 1.36 Million GBP | -12.3% |
2019 | 1.55 Million GBP | 0.0% |
2018 | - GBP | 0.0% |
2017 | - GBP | 0.0% |
2016 | - GBP | 0.0% |
2015 | - GBP | 0.0% |
2014 | - GBP | 0.0% |
2013 | - GBP | -100.0% |
2012 | 131.75 Thousand GBP | 0.57% |
2011 | 131 Thousand GBP | -40.99% |
2010 | 222 Thousand GBP | 126.53% |
2009 | 98 Thousand GBP | -69.47% |
2008 | 321 Thousand GBP | 146.92% |
2007 | 130 Thousand GBP | 465.22% |
2006 | 23 Thousand GBP | -51.06% |
2005 | 47 Thousand GBP | 0.0% |
2004 | 47 Thousand GBP | 571.43% |
2003 | 7000.00 GBP | -41.67% |
2002 | 12 Thousand GBP | -55.56% |
2001 | 27 Thousand GBP | 125.0% |
2000 | 12 Thousand GBP | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | - GBP | 0.0% |
2024 Q1 | - GBP | -100.0% |
2023 Q1 | 3.96 Million GBP | -20.8% |
2023 FY | 4.55 Million GBP | -8.94% |
2023 Q3 | 3.9 Million GBP | -14.63% |
2023 Q4 | 4.55 Million GBP | 16.62% |
2023 Q2 | 4.57 Million GBP | 15.48% |
2022 Q3 | 4.33 Million GBP | -17.15% |
2022 Q2 | 5.23 Million GBP | 12.09% |
2022 Q1 | 4.67 Million GBP | 99.83% |
2022 FY | 5 Million GBP | 113.9% |
2022 Q4 | 5 Million GBP | 15.26% |
2021 Q2 | 2.6 Million GBP | 35.46% |
2021 Q4 | 2.33 Million GBP | 28.74% |
2021 FY | 2.33 Million GBP | 71.66% |
2021 Q1 | 1.92 Million GBP | 41.41% |
2021 Q3 | 1.81 Million GBP | -30.39% |
2020 Q2 | 1.61 Million GBP | 0.0% |
2020 Q4 | 1.36 Million GBP | 46.77% |
2020 Q3 | 928 Thousand GBP | -42.4% |
2020 FY | 1.36 Million GBP | -12.3% |
2020 Q1 | 1.61 Million GBP | 0.0% |
2019 Q3 | 1.49 Million GBP | 0.0% |
2019 Q1 | - GBP | 0.0% |
2019 FY | 1.55 Million GBP | 0.0% |
2019 Q2 | - GBP | 0.0% |
2018 Q1 | - GBP | 0.0% |
2018 Q3 | - GBP | 0.0% |
2018 FY | - GBP | 0.0% |
2018 Q4 | - GBP | 0.0% |
2017 Q4 | - GBP | 0.0% |
2017 Q3 | - GBP | 0.0% |
2017 Q2 | - GBP | 0.0% |
2017 Q1 | - GBP | 0.0% |
2017 FY | - GBP | 0.0% |
2016 Q2 | - GBP | 0.0% |
2016 Q1 | - GBP | 0.0% |
2016 Q3 | - GBP | 0.0% |
2016 Q4 | - GBP | 0.0% |
2016 FY | - GBP | 0.0% |
2015 FY | - GBP | 0.0% |
2015 Q2 | - GBP | 0.0% |
2015 Q3 | - GBP | 0.0% |
2015 Q4 | - GBP | 0.0% |
2015 Q1 | - GBP | 0.0% |
2014 Q3 | - GBP | 0.0% |
2014 Q4 | - GBP | 0.0% |
2014 FY | - GBP | 0.0% |
2014 Q2 | - GBP | 0.0% |
2014 Q1 | - GBP | 0.0% |
2013 FY | - GBP | -100.0% |
2013 Q2 | 132 Thousand GBP | 0.19% |
2013 Q3 | 132 Thousand GBP | 0.0% |
2013 Q4 | - GBP | -100.0% |
2013 Q1 | 131.75 Thousand GBP | -0.19% |
2012 FY | 131.75 Thousand GBP | 0.57% |
2012 Q4 | 132 Thousand GBP | 0.19% |
2012 Q3 | 131.75 Thousand GBP | 0.0% |
2012 Q2 | 131.75 Thousand GBP | -0.19% |
2012 Q1 | 132 Thousand GBP | 0.0% |
2011 FY | 131 Thousand GBP | -40.99% |
2011 Q3 | 132 Thousand GBP | 0.0% |
2011 Q1 | 222 Thousand GBP | 0.0% |
2010 Q3 | 225 Thousand GBP | 0.0% |
2010 FY | 222 Thousand GBP | 126.53% |
2010 Q1 | 98 Thousand GBP | 0.0% |
2009 Q3 | 288 Thousand GBP | 0.0% |
2009 Q1 | 321 Thousand GBP | 0.0% |
2009 FY | 98 Thousand GBP | -69.47% |
2008 FY | 321 Thousand GBP | 146.92% |
2008 Q3 | 186 Thousand GBP | 0.0% |
2008 Q1 | 131 Thousand GBP | 0.0% |
2007 FY | 130 Thousand GBP | 465.22% |
2007 Q3 | 86 Thousand GBP | 0.0% |
2007 Q1 | 23 Thousand GBP | 0.0% |
2006 Q1 | 47 Thousand GBP | 0.0% |
2006 FY | 23 Thousand GBP | -51.06% |
2006 Q3 | 32 Thousand GBP | 0.0% |
2005 Q1 | 6000.00 GBP | 0.0% |
2005 FY | 47 Thousand GBP | 0.0% |
2005 Q3 | 57 Thousand GBP | 0.0% |
2004 Q3 | 10 Thousand GBP | 0.0% |
2004 Q1 | 7000.00 GBP | 0.0% |
2004 FY | 47 Thousand GBP | 571.43% |
2003 FY | 7000.00 GBP | -41.67% |
2003 Q3 | - GBP | 0.0% |
2002 FY | 12 Thousand GBP | -55.56% |
2001 FY | 27 Thousand GBP | 125.0% |
2000 FY | 12 Thousand GBP | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | -103.304% |
Arrayit Corporation | 1.07 Million USD | -322.384% |
Atlantic International Corp. | 2.93 Million USD | -55.401% |
Biocept, Inc. | 12.1 Million USD | 62.392% |
Bioqual, Inc. | 3.58 Million USD | -26.959% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -6171.518% |
DermTech, Inc. | 54.39 Million USD | 91.628% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.035% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 5.791% |
iMD Companies, Inc. | 1.12 Million USD | -306.553% |
IDenta Corp. | 789.14 Thousand USD | -477.08% |
Interpace Biosciences, Inc. | 11.19 Million USD | 59.31% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -10286.589% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 43.393% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | -19.031% |
NovelStem International Corp. | 3.57 Million USD | -27.399% |
Optigenex Inc. | 8.94 Million USD | 49.065% |
PharmChem, Inc. | 77.35 Thousand USD | -5787.296% |
Proteome Sciences plc | 17.15 Million USD | 73.452% |
Response Genetics, Inc | 6.37 Million USD | 28.542% |
Rennova Health, Inc. | 15.32 Million USD | 70.292% |
RushNet, Inc. | 4.82 Million USD | 5.579% |
ScreenPro Security Inc. | 207.03 Thousand USD | -2099.639% |
Stella Diagnostics Inc. | 6.2 Million USD | 26.557% |
StageZero Life Sciences Ltd. | 1.8 Million USD | -152.988% |
Todos Medical Ltd. | 38.34 Million USD | 88.125% |